Employer Coverage for GLP-1s: How to Check and What to Ask HR

You want to know if your job’s health plan covers Wegovy, Zepbound, or Ozempic, and how to find that out without guessing. Short answer: pull up your Summary of Benefits, call the number on your insurance card, and then go talk to HR with a short list of specific questions. Employer coverage for GLP-1 drugs is not a yes or no thing anymore. It depends on your plan type, your company’s size, and a formulary decision your employer might have made without telling anyone.

Let’s get into it.

Quick verdict

This guide is for you if you have a job with health insurance and you’re trying to figure out, before you talk to a doctor, whether your plan will cover a GLP-1.

Skip this if: you’re on Medicare or Medicaid. Those have their own rules, and we won’t get into them here.

The honest bottom line: roughly one in three large employers covered GLP-1s for weight loss as of mid 2026, and that number moved in both directions this year. Some big employers added coverage. Some, including Cigna’s own employee plan, dropped it. So you really do need to check your specific plan, not just Google “does my insurance cover Ozempic” and trust the first answer.

How common is employer coverage for GLP-1s right now?

Here’s where things stand. Employer coverage of GLP-1 medications for weight loss sits somewhere between 16% and 43% depending on whose survey you read and how big the company is. Business Group on Health puts the number for large employers around 36% as of mid 2026. Bigger companies cover it more often. Small businesses cover it a lot less.

And 2026 has been a bumpy year for this. Mercer reported that 6% of large employers dropped GLP-1 coverage this year. Blue Cross Blue Shield of Massachusetts told members that as of January 1, 2026, Wegovy, Saxenda, and Zepbound are excluded from plans at renewal, unless the employer group has more than 100 people and chooses to keep the benefit. Cigna went further and cut GLP-1 weight loss coverage from its own employee health plan starting July 1, 2026.

But it’s not all bad news. CVS Caremark, one of the biggest pharmacy benefit managers in the country, announced Zepbound is coming back onto standard formularies starting October 2026. That alone could open coverage up for 25 to 30 million people, though again, your employer still has to opt in.

So here’s the thing. None of these headlines tell you what YOUR plan does. You’ve gotta check it yourself.

How to actually check if your plan covers Wegovy or Zepbound

Before you even call HR, do this first:

1. Find your Summary of Benefits and Coverage (SBC). It’s usually a PDF on your insurance company’s member portal. Search it for “weight loss,” “obesity,” or “GLP-1.”
2. Call the number on the back of your insurance card. Ask the rep directly: “Is [drug name] covered under my plan, and if so, what’s the prior authorization criteria?” Write down who you talked to and when.
3. Ask about the diagnosis code. This matters a ton. A lot of plans cover semaglutide for type 2 diabetes (that’s Ozempic) but not for weight loss (that’s Wegovy), even though it’s the same drug. Some plans cover Wegovy only if it’s prescribed for cardiovascular risk reduction, not plain weight loss.
4. Check the tier. GLP-1s usually sit on tier 3 or tier 4 (specialty), which means a higher copay even when they are covered.

If the answer from your insurer is confusing or you get two different answers from two different reps (this happens more than you’d think), that’s your cue to go to HR.

What to ask HR about employer coverage for GLP-1s

This is the part most people skip, and it’s the most useful part. Your HR benefits team, or whoever manages your company’s health plan, knows things your insurance company’s phone reps often don’t.

Ask if your plan is self-funded or fully insured.

This one question changes everything. If your employer is self-funded, meaning they pay the claims themselves and just use an insurance company to administer the plan, then your employer decides what’s on the formulary. A fully insured plan follows the insurer’s standard rules more closely. Self-funded employers have way more room to add or drop GLP-1 coverage, sometimes with almost no notice to employees.

Ask about any exclusion list or lifetime limits.

Some employers cover GLP-1s but cap it. The University of Michigan, for example, put a lifetime limit of 24 monthly fills on GLP-1s used only for weight loss. That’s a real benefit design choice, not an insurance company rule, and appeals usually don’t work against it because it’s written into the plan document.

Ask what the prior authorization actually requires.

Most plans that do cover GLP-1s for weight loss want a BMI of 30 or higher, or 27 with a condition like high blood pressure or sleep apnea. Ask HR (or the PBM directly) for the exact criteria in writing. Bring this to your doctor’s office before your appointment so they can document the right things the first time.

Ask what happens if you’re denied.

Ask about the appeals process now, before you need it. Fewer than 1% of denied claims on the individual market ever get appealed, mostly because people don’t know how or give up. Ask HR who handles appeals for your plan (sometimes it’s the insurer, sometimes a separate PBM like CVS Caremark or Express Scripts) and get a name or a process in writing.

Ask if coverage is changing at the next renewal.

Open enrollment is honestly the best time to ask this. Coverage that exists in September might disappear in January. If your plan is renewing soon, ask directly: “Is GLP-1 coverage changing for the next plan year?” HR may not always know yet, but it’s worth asking early and asking again closer to renewal.

Sounds like a lot of questions, right? It kind of is. But one email to HR with all five of these can save you weeks of back and forth with an insurance phone line.

If your employer doesn’t cover it, what are the real cash pay options?

If you’ve checked and the answer is no, you’re not totally stuck. Both major manufacturers now sell direct.

Wegovy through NovoCare (Novo Nordisk’s own pharmacy): as of today, checking NovoCare’s official pricing page directly, the Wegovy pill runs $149 a month at the starter dose and $299 a month at the higher maintenance doses. The Wegovy pen has a limited-time offer of $199 for your first two months for new patients, then $349 a month after that, and $399 a month for the higher-dose Wegovy HD pen. That’s a long way down from the $1,349 list price Novo Nordisk shows on the same page.

Zepbound through LillyDirect (Eli Lilly’s own pharmacy): based on Lilly’s Self Pay Journey Program, which multiple pharmacy and industry sources report consistently, pricing runs $299 a month for the 2.5 mg starter dose, $399 a month for 5 mg, and $449 a month for the higher maintenance doses (7.5 mg through 15 mg), as long as you refill within 45 days. Miss that window on a higher dose and the price can jump back up to $499 or more. I wasn’t able to load Lilly’s own self-pay page directly today, so treat that last detail as reported by several pharmacy pricing trackers rather than something I read on lillydirect.lilly.com myself.

Pick Wegovy’s pill if you want the lowest entry price and don’t mind a daily pill instead of a weekly shot. Pick Zepbound if tirzepatide is the one your doctor recommends for you specifically, since the two drugs aren’t interchangeable.

FAQ

Does insurance ever cover Ozempic for weight loss? Generally no. Ozempic is FDA approved for type 2 diabetes, not weight loss. If you don’t have diabetes, ask your doctor about Wegovy instead, since that’s the version actually approved for weight management.

What’s the difference between self-funded and fully insured for GLP-1 coverage? A self-funded employer pays the claims out of its own pocket and sets its own formulary rules, so coverage can vary a lot company to company. A fully insured plan follows the insurance carrier’s standard formulary more closely.

Will my employer’s GLP-1 coverage still be there next year? Maybe, maybe not. Business Group on Health found that 72% of employers who currently cover GLP-1s plan to keep doing so in 2027, but 10% said they likely won’t. Ask HR directly at your next open enrollment.

Can I get GLP-1s covered if my employer excludes weight loss but covers diabetes? Only if you actually have type 2 diabetes and your doctor prescribes an approved diabetes drug like Ozempic or Mounjaro. Using a diabetes diagnosis you don’t have to get weight loss coverage is insurance fraud, so don’t do that.

Does compounded semaglutide count as covered by insurance? No. Compounded GLP-1s aren’t FDA approved as finished products, so no commercial insurance plan, Medicare, or Medicaid covers them. That’s a cash pay category only.

My honest take

I’ll be straight with you. Employer coverage for GLP-1s in 2026 is a moving target, and it’s genuinely frustrating that the answer can change between January and July of the same year. What surprised me most putting this together is how much power self-funded employers actually have here. Your company, not just your insurance card, might be the real decision maker. So don’t stop at “check your insurance.” Check with HR too, get answers in writing, and ask again at renewal. And if the answer really is no for now, the direct manufacturer prices are a lot more livable than the sticker price most people assume is the only option. Talk with your doctor about which drug and which path actually fits your situation. This isn’t medical advice, just a map for the insurance and HR side of things.